Cobalt and GlaxoSmithKline Finally Reach Settlement

Michael Coyle
February 26, 2007

It was announced on 15 November 2006 that Cobalt Laboratories Inc. has reached a patent litigation settlement with GlaxoSmithKline Plc. regarding its Âsumatriptan succinate tabletsÂ, the generic version of GlaxoSmithKline’s Imitrex, which is sold to treat migraine pain.

Cobalt Pharmaceuticals Inc. announced in a statement that the company may distribute a genericÂ version in the U.S. by the first quarter of 2009 following the settlement which remains subject toÂ government review.

This was just one term that was agreed between lawyers, but the statement did not provideÂ additional details on the other terms of the settlement.

share this Article

Recent Articles

Media organisation hits Snoop Dogg with copyright infringement lawsuit

Snoop Dogg, real name Calvin Cordozar Broadus Jr, has found himself on the receiving end of a copyright infringement lawsuit, after posting a video of

Copycat Chinese squid game TV show shot down

It has recently been announced that Squid Game is the most viewed show on Netflix and has been watched by thousands and thousands of people

How are NFT’s regulated in the UK?

The Financial Conduct Authority (FCA) has not yet provided guidance on NFT’s specifically with regards to regulation in the United Kingdom (UK). However, the FCA

Need Legal Advice? Book a Free Consultation

Lawdit ® Solicitors is the trading name of Lawdit Solicitors Ltd. Regulated by the Solicitors Regulation Authority of England and Wales.

Southampton Office

Isle of Wight Office

Quick Links

Lawdit ® Solicitors © 2021. All Rights Reserved.

Website by Nosy.Marketing